These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 16322132

  • 1. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
    Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
    [Abstract] [Full Text] [Related]

  • 2. Arthritis presenting during the acute phase of Kawasaki disease.
    Gong GW, McCrindle BW, Ching JC, Yeung RS.
    J Pediatr; 2006 Jun; 148(6):800-5. PubMed ID: 16769390
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D, Wong M, Isaacs D.
    J Paediatr Child Health; 2005 Jun; 41(9-10):495-9. PubMed ID: 16150066
    [Abstract] [Full Text] [Related]

  • 4. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC, Aronoff SC.
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [Abstract] [Full Text] [Related]

  • 8. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

  • 9. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P, Ausili E, Schiavino A, Angelone DF, Focarelli B, De Rosa G, Ranno O.
    Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
    [Abstract] [Full Text] [Related]

  • 10. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 11. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
    [Abstract] [Full Text] [Related]

  • 12. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
    Raith W, Gamillscheg A, Heinzl B, Nagel BH, Koestenberger M, Beitzke A.
    Klin Padiatr; 2009 Nov 27; 221(2):83-8. PubMed ID: 19263328
    [Abstract] [Full Text] [Related]

  • 13. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug 27; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroid treatment of refractory Kawasaki disease.
    Lang BA, Yeung RS, Oen KG, Malleson PN, Huber AM, Riley M, Ebbeson R, Ramsey SE, Laxer RM, Silverman ED, McCrindle BW, Ratnapalan S, Feldman BM.
    J Rheumatol; 2006 Apr 27; 33(4):803-9. PubMed ID: 16583481
    [Abstract] [Full Text] [Related]

  • 15. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.
    Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T.
    J Paediatr Child Health; 2008 Jun 27; 44(6):359-62. PubMed ID: 18476929
    [Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 27; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov 27; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 18. The diagnosis and management of Kawasaki disease.
    Royle J, Burgner D, Curtis N.
    J Paediatr Child Health; 2005 Mar 27; 41(3):87-93. PubMed ID: 15790316
    [Abstract] [Full Text] [Related]

  • 19. [Cardiovascular complications of Kawasaki disease: clinical cases].
    Sica F, d'Amato E, Colapietra T, Romondia A.
    Pediatr Med Chir; 1995 Mar 27; 17(6):531-3. PubMed ID: 8668589
    [Abstract] [Full Text] [Related]

  • 20. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N, Heaton P, Calder L, Nicholson R, Stables S, Gavin R.
    J Paediatr Child Health; 2004 Mar 27; 40(9-10):524-9. PubMed ID: 15367145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.